Anakinra: An effective treatment in the Schnitzler syndrome

Joint Bone Spine

Volumn 78, Issue 6, 2011, Pages 636-637

  Vandenhende, Marie Anne ^a   Bentaberry, Fabrice ^a   Morlat, Philippe ^a   Bonnet, Fabrice ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Anakinra; Interleukin 1; Monoclonal gammapathy; Schnitzler syndrome; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; COLCHICINE; CORTICOSTEROID; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INJECTION SITE REACTION; LOW DRUG DOSE; MALE; RASH; REMISSION; SCHNITZLER SYNDROME; TREATMENT OUTCOME; URTICARIA;

ANTIRHEUMATIC AGENTS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; REMISSION INDUCTION; SCHNITZLER SYNDROME; TREATMENT OUTCOME;

EID: 84855962859     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.03.021     Document Type: Article

References (14)

1. Lipsker D., Veran Y., Grunenberger F., et al. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001, 80:37-44.
2. de Koning H.D., Bodar E.J., van der Meer J.W., et al. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007, 37:137-148.
3. Lipsker D., Spehner D., Drillien R., et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 2000, 142:954-959.
4. Eiling E., Schroder J.O., Gross W.L., et al. The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy-an autoinflammatory syndrome?. J Dtsch Dermatol Ges 2008, 6:626-631.
5. Ramadan K.M., Eswedi H.A., El-Agnaf M.R. Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br J Dermatol 2007, 156:1072-1074.
6. Cascavilla N., Bisceglia M., D'Arena G. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Int J Immunopathol Pharmacol 2010, 23:633-636.
7. Tinazzi E., Puccetti A., Patuzzo G., et al. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: Report of two new cases and review of the literature. Autoimmun Rev 2011, 10.1016/j.autrev.2011.01.003.
8. Dinarello C.A. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 2009, 360:2467-2470.
9. Saurat J.H., Schifferli J., Steiger G., et al. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition-higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991, 88:244-256.
10. Farasat S., Aksentijevich I., Toro J.R. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol 2008, 144:392-402.
11. Molto A., Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine 2010, 77:102-107.
12. de Koning H.D., Bodar E.J., Simon A., et al. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006, 65:542-544.
13. Besada E., Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010, 29:567-571.
14. Schuster C., Kranke B., Aberer E., et al. Schnitzler syndrome: response to anakinra in two cases and a review of the literature. Int J Dermatol 2009, 48:1190-1194.